Lee Walmsley

4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer

Paul A. Brough, Wynne Aherne, Xavier Barril et al. · Journal of Medicinal Chemistry · 2007 · 442 citations · Full text

Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B

Lee Walmsley, James B. Murray, P. Dokurno et al. · Journal of Medicinal Chemistry · 2021 · 35 citations · Full text

Fragment-derived Selective Inhibitors, Chemoprevention Strategy, Novel Therapy +13

Structure-Guided Discovery of Potent and Selective DYRK1A Inhibitors

Csaba Wéber, Melinda Sipos, Attila Paczal et al. · Journal of Medicinal Chemistry · 2021 · 33 citations · Full text

Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity

Yousuke Yamada, Hajime Takashima, Lee Walmsley et al. · Journal of Medicinal Chemistry · 2020 · 29 citations · Full text

Targeting DYRK1A/B kinases to modulate p21‐cyclin D1‐p27 signalling and induce anti‐tumour activity in a model of human glioblastoma

Andrew J. Massey, Karen Benwell, Mike F. Burbridge et al. · Journal of Cellular and Molecular Medicine · 2021 · 25 citations · Full text